CSO Karin von Wachenfeldt presents Amplio Pharma at Life Science Summit 2026.
The content of BioStock’s news and analysis is independent, but BioStock’s operations are to some extent financed by companies in the industry. This post refers to a company from which BioStock has received funding.
